Evidence shows that PSPC1 augments cell adhesion and motility by promoting insulin-like growth factor 1 receptor expression to stimulate downstream focal adhesion and integrin signaling pathways [63], as well as activation of EMT and CSC, in association with a higher risk of metastasis and a poorer prognosis for patients with cancer [24,64]. This evidence concerns the gene PSPC1 and cancer.